The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124131153 12413115 3 F 20140320 20160714 20160527 20160715 EXP IL-PFIZER INC-2016250616 PFIZER 60.00 YR M Y 65.00000 KG 20160715 OT IL IL

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124131153 12413115 1 PS SILDENAFIL CITRATE. SILDENAFIL CITRATE 1 10 MG, X3 Y 21845 10 MG FILM-COATED TABLET
124131153 12413115 2 SS SILDENAFIL CITRATE. SILDENAFIL CITRATE 1 20 MG, TIMES 3 Y 21845 20 MG FILM-COATED TABLET
124131153 12413115 3 SS PLACEBO UNSPECIFIED INGREDIENT 1 20 MG, X3 Y 0 20 MG
124131153 12413115 4 C CARDILOC BISOPROLOL FUMARATE 1 Oral 10 MG, UNK 0 10 MG
124131153 12413115 5 C LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM 1 Oral 50 MG, X2 0 50 MG
124131153 12413115 6 C INSPRA EPLERENONE 1 Oral 25 MG, UNK 0 25 MG
124131153 12413115 7 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 20 MG, UNK 0 20 MG
124131153 12413115 8 C GLUCOPHAGE METFORMIN HYDROCHLORIDE 1 Oral 850 MG, X2 0 850 MG
124131153 12413115 9 C LOSEC OMEPRAZOLE 1 20 MG, UNK 0 20 MG
124131153 12413115 10 C VABEN OXAZEPAM 1 10 MG, UNK 0 10 MG
124131153 12413115 11 C BONDORMIN BROTIZOLAM 1 0.25 MG 0 .25 MG
124131153 12413115 12 C FUSID /00032601/ 2 60 MG, X2 0 60 MG
124131153 12413115 13 C VITAMIN B1 THIAMINE HYDROCHLORIDE 1 100 MG, UNK 0 100 MG
124131153 12413115 14 C DIGOXIN. DIGOXIN 1 0.125 MG, UNK 0 .125 MG
124131153 12413115 15 C FERIFOL 2 UNK 0
124131153 12413115 16 C COUMADIN WARFARIN SODIUM 1 0
124131153 12413115 17 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Oral 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124131153 12413115 1 Pulmonary hypertension
124131153 12413115 3 Pulmonary hypertension
124131153 12413115 4 Cardiac failure
124131153 12413115 5 Cardiac failure
124131153 12413115 6 Cardiac failure
124131153 12413115 7 Dyslipidaemia
124131153 12413115 8 Diabetes mellitus
124131153 12413115 9 Prophylaxis
124131153 12413115 10 Anxiety
124131153 12413115 11 Insomnia
124131153 12413115 12 Cardiac failure
124131153 12413115 13 Prophylaxis
124131153 12413115 14 Cardiac failure
124131153 12413115 15 Anaemia
124131153 12413115 16 Atrial fibrillation

Outcome of event

Event ID CASEID OUTC COD
124131153 12413115 DS
124131153 12413115 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
124131153 12413115 Anal incontinence
124131153 12413115 Gouty arthritis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124131153 12413115 1 20140216 20140301 0
124131153 12413115 2 20140302 20140330 0
124131153 12413115 3 20140302 20140330 0